Metabolic disposition of the new fluoroquinolone antibacterial agent DW116 in rats

Drug Metabolism and Disposition

Volumn 25, Issue 9, 1997, Pages 1101-1103

  Park, Jongsei ^a   Park, Y H ^b   Jung, B H ^b   Chung, B C ^b   Mitoma, C ^b  

^a Korea Institute of Science and Technology   (South Korea)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

FANDOFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BILE FLOW; CONTROLLED STUDY; DRUG CLEARANCE; DRUG CONJUGATION; DRUG DISPOSITION; DRUG EXCRETION; DRUG METABOLISM; DRUG TRANSPORT; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY CLEARANCE; LIVER CLEARANCE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; ORAL DRUG ADMINISTRATION; PLACENTAL TRANSFER; PRIORITY JOURNAL; RAT;

ADMINISTRATION, ORAL; ANIMALS; ANTI-INFECTIVE AGENTS; AREA UNDER CURVE; BILE; FLUOROQUINOLONES; HALF-LIFE; INJECTIONS, INTRAVENOUS; MALE; METABOLIC CLEARANCE RATE; PIPERAZINES; QUINOLONES; RATS; RATS, SPRAGUE-DAWLEY; TISSUE DISTRIBUTION;

ANIMALIA;

EID: 0030767234     PISSN: 00909556     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (5)

1. R. J. Reece and A. Maxwell: DNA gyrase: structure and function. Crit. Rev. Biochem. Mol. Biol. 26, 335-375 (1991).
2. D. T. W. Chu and P. B. Fernandes: Recent developments in the field of quinolone antibacterial agents. Adv. Drug Res. 21, 39-144 (1991).
3. K. Vance-Bryan, D. R. P. Guay, and J. C. Rotschafer: Clinical pharmacokinetics of ciprofloxacin. Clin. Pharmacokinet. 19, 434-461 (1990).
4. S. J. Yun and et al.: The study on the development of DW 116, new quinolone class of antibacterial agent. Dong Wha Pharmaceutical Industry Company, Technical Report, 1994.
5. K. I. Plaisance, G. L. Drusano, A. Forrest, C. L., Bustamante, and H. C. Standiford: Effect of dose size on bioavailability of ciprofloxacin. Antimicrob. Agents Chemother. 31, 956-958 (1987).